<table width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 7: Drug Interactions: Pharmacokinetic Parameters for Rilpivirine in the Presence of Co-administered Drugs</caption>
<col align="left" valign="top" width="16%"></col>
<col align="center" valign="top" width="16%"></col>
<col align="center" valign="top" width="16%"></col>
<col align="center" valign="top" width="7%"></col>
<col align="center" valign="top" width="15%"></col>
<col align="center" valign="top" width="15%"></col>
<col align="center" valign="top" width="15%"></col>
<thead>
<tr>
<th rowspan="2" stylecode="Lrule Rrule" valign="bottom">Co-administered Drug</th>
<th colspan="2" stylecode="Botrule Rrule" valign="bottom">Dose/Schedule</th>
<th rowspan="2" stylecode="Rrule" valign="bottom">N</th>
<th colspan="3" stylecode="Botrule Rrule" valign="bottom">Mean Ratio of <content stylecode="underline">Rilpivirine</content>
<br/>Pharmacokinetic Parameters<br/>With/Without Co-administered Drug<br/>(90% CI); No Effect = 1.00</th>
</tr>
<tr>
<th align="center" stylecode="Rrule" valign="bottom">Co-administered Drug</th>
<th stylecode="Rrule" valign="bottom">Rilpivirine</th>
<th stylecode="Rrule" valign="bottom">C<sub>max</sub>
</th>
<th stylecode="Rrule" valign="bottom">AUC</th>
<th stylecode="Rrule" valign="bottom">C<sub>min</sub>
</th>
</tr>
</thead>
<tfoot>
<tr>
<td align="left" colspan="7">CI = Confidence Interval; N = maximum number of subjects with data; N.A. = not available; ↑ = increase; ↓ = decrease; ↔ = no change; q.d. = once daily; b.i.d. = twice daily</td>
</tr>
</tfoot>
<tbody>
<tr stylecode="Botrule">
<td colspan="7" stylecode="Lrule Rrule">
<content stylecode="bold">Co-Administration With HIV Protease Inhibitors (PIs)</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Darunavir/ritonavir</td>
<td stylecode="Rrule">800/100 mg q.d.</td>
<td stylecode="Rrule">150 mg q.d.<footnote id="t6fn1">This interaction study has been performed with a dose higher than the recommended dose for EDURANT (25 mg once daily) assessing the maximal effect on the co-administered drug.</footnote>
</td>
<td stylecode="Rrule">14</td>
<td stylecode="Rrule">1.79<br/>(1.56–2.06)</td>
<td stylecode="Rrule">2.30<br/>(1.98–2.67)</td>
<td stylecode="Rrule">2.78<br/>(2.39–3.24)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Lopinavir/ritonavir (soft gel capsule)</td>
<td stylecode="Rrule">400/100 mg b.i.d.</td>
<td stylecode="Rrule">150 mg q.d.<footnoteref idref="t6fn1"></footnoteref>
</td>
<td stylecode="Rrule">15</td>
<td stylecode="Rrule">1.29<br/>(1.18–1.40)</td>
<td stylecode="Rrule">1.52<br/>(1.36–1.70)</td>
<td stylecode="Rrule">1.74<br/>(1.46–2.08)</td>
</tr>
<tr stylecode="Botrule">
<td colspan="7" stylecode="Lrule Rrule">
<content stylecode="bold">Co-Administration With HIV Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTIs/N[t]RTIs)</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Didanosine</td>
<td stylecode="Rrule">400 mg q.d.<br/>delayed release capsules taken 2 hours before rilpivirine</td>
<td stylecode="Rrule">150 mg q.d.<footnoteref idref="t6fn1"></footnoteref>
</td>
<td stylecode="Rrule">21</td>
<td stylecode="Rrule">1.00<br/>(0.90–1.10)</td>
<td stylecode="Rrule">1.00<br/>(0.95–1.06)</td>
<td stylecode="Rrule">1.00<br/>(0.92–1.09)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Tenofovir disoproxil fumarate</td>
<td stylecode="Rrule">300 mg q.d.</td>
<td stylecode="Rrule">150 mg q.d.<footnoteref idref="t6fn1"></footnoteref>
</td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">0.96<br/>(0.81–1.13)</td>
<td stylecode="Rrule">1.01<br/>(0.87–1.18)</td>
<td stylecode="Rrule">0.99<br/>(0.83–1.16)</td>
</tr>
<tr stylecode="Botrule">
<td colspan="7" stylecode="Lrule Rrule">
<content stylecode="bold">Co-Administration With HIV Integrase Strand Transfer Inhibitors</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Raltegravir</td>
<td stylecode="Rrule">400 mg b.i.d.</td>
<td stylecode="Rrule">25 mg q.d.</td>
<td stylecode="Rrule">23</td>
<td stylecode="Rrule">1.12<br/>(1.04–1.20)</td>
<td stylecode="Rrule">1.12<br/>(1.05–1.19)</td>
<td stylecode="Rrule">1.03<br/>(0.96–1.12)</td>
</tr>
<tr stylecode="Botrule">
<td colspan="7" stylecode="Lrule Rrule">
<content stylecode="bold">Co-Administration With other Antivirals</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Telaprevir</td>
<td stylecode="Rrule">750 mg q8h</td>
<td stylecode="Rrule">25 mg q.d.</td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">1.49<br/>(1.20–1.84)</td>
<td stylecode="Rrule">1.78<br/>(1.44–2.20)</td>
<td stylecode="Rrule">1.93<br/>(1.55–2.41)</td>
</tr>
<tr stylecode="Botrule">
<td colspan="7" stylecode="Lrule Rrule">
<content stylecode="bold">Co-Administration With Drugs other than Antiretrovirals</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Acetaminophen</td>
<td stylecode="Rrule">500 mg single dose</td>
<td stylecode="Rrule">150 mg q.d.<footnoteref idref="t6fn1"></footnoteref>
</td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">1.09<br/>(1.01–1.18)</td>
<td stylecode="Rrule">1.16<br/>(1.10–1.22)</td>
<td stylecode="Rrule">1.26<br/>(1.16–1.38)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Atorvastatin</td>
<td stylecode="Rrule">40 mg q.d.</td>
<td stylecode="Rrule">150 mg q.d.<footnoteref idref="t6fn1"></footnoteref>
</td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">0.91<br/>(0.79–1.06)</td>
<td stylecode="Rrule">0.90<br/>(0.81–0.99)</td>
<td stylecode="Rrule">0.90<br/>(0.84–0.96)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Chlorzoxazone</td>
<td stylecode="Rrule">500 mg single dose taken 2 hours after rilpivirine</td>
<td stylecode="Rrule">150 mg q.d.<footnoteref idref="t6fn1"></footnoteref>
</td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">1.17<br/>(1.08–1.27)</td>
<td stylecode="Rrule">1.25<br/>(1.16–1.35)</td>
<td stylecode="Rrule">1.18<br/>(1.09–1.28)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Ethinylestradiol/Norethindrone</td>
<td stylecode="Rrule">0.035 mg q.d./<br/>1 mg q.d.</td>
<td stylecode="Rrule">25 mg q.d.</td>
<td stylecode="Rrule">15</td>
<td stylecode="Rrule">↔<footnote id="t6fn2">comparison based on historic controls</footnote>
</td>
<td stylecode="Rrule">↔<footnoteref idref="t6fn2"></footnoteref>
</td>
<td stylecode="Rrule">↔<footnoteref idref="t6fn2"></footnoteref>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Famotidine</td>
<td stylecode="Rrule">40 mg single dose taken 12 hours before rilpivirine</td>
<td stylecode="Rrule">150 mg single dose<footnoteref idref="t6fn1"></footnoteref>
</td>
<td stylecode="Rrule">24</td>
<td stylecode="Rrule">0.99<br/>(0.84–1.16)</td>
<td stylecode="Rrule">0.91<br/>(0.78–1.07)</td>
<td stylecode="Rrule">N.A.</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Famotidine</td>
<td stylecode="Rrule">40 mg single dose taken 2 hours before rilpivirine</td>
<td stylecode="Rrule">150 mg single dose<footnoteref idref="t6fn1"></footnoteref>
</td>
<td stylecode="Rrule">23</td>
<td stylecode="Rrule">0.15<br/>(0.12–0.19)</td>
<td stylecode="Rrule">0.24<br/>(0.20–0.28)</td>
<td stylecode="Rrule">N.A.</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Famotidine</td>
<td stylecode="Rrule">40 mg single dose taken 4 hours after rilpivirine</td>
<td stylecode="Rrule">150 mg single dose<footnoteref idref="t6fn1"></footnoteref>
</td>
<td stylecode="Rrule">24</td>
<td stylecode="Rrule">1.21<br/>(1.06–1.39)</td>
<td stylecode="Rrule">1.13<br/>(1.01–1.27)</td>
<td stylecode="Rrule">N.A.</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Ketoconazole</td>
<td stylecode="Rrule">400 mg q.d.</td>
<td stylecode="Rrule">150 mg q.d.<footnoteref idref="t6fn1"></footnoteref>
</td>
<td stylecode="Rrule">15</td>
<td stylecode="Rrule">1.30<br/>(1.13–1.48)</td>
<td stylecode="Rrule">1.49<br/>(1.31–1.70)</td>
<td stylecode="Rrule">1.76<br/>(1.57–1.97)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Methadone</td>
<td stylecode="Rrule">60–100 mg q.d., individualised dose</td>
<td stylecode="Rrule">25 mg q.d.</td>
<td stylecode="Rrule">12</td>
<td stylecode="Rrule">↔<footnoteref idref="t6fn2"></footnoteref>
</td>
<td stylecode="Rrule">↔<footnoteref idref="t6fn2"></footnoteref>
</td>
<td stylecode="Rrule">↔<footnoteref idref="t6fn2"></footnoteref>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Omeprazole</td>
<td stylecode="Rrule">20 mg q.d.</td>
<td stylecode="Rrule">150 mg q.d.<footnoteref idref="t6fn1"></footnoteref>
</td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">0.60<br/>(0.48–0.73)</td>
<td stylecode="Rrule">0.60<br/>(0.51–0.71)</td>
<td stylecode="Rrule">0.67<br/>(0.58–0.78)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Rifabutin</td>
<td stylecode="Rrule">300 mg q.d.</td>
<td stylecode="Rrule">25 mg q.d.</td>
<td stylecode="Rrule">18</td>
<td stylecode="Rrule">0.69<br/>(0.62–0.76)</td>
<td stylecode="Rrule">0.58<br/>(0.52–0.65)</td>
<td stylecode="Rrule">0.52<br/>(0.46–0.59)</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Rifabutin</td>
<td stylecode="Rrule">300 mg q.d.</td>
<td stylecode="Rrule">50 mg q.d.</td>
<td stylecode="Rrule">18</td>
<td stylecode="Rrule">1.43<br/>(1.30–1.56)</td>
<td stylecode="Rrule">1.16<br/>(1.06–1.26)</td>
<td stylecode="Rrule">0.93<br/>(0.85–1.01)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td align="center" colspan="3" stylecode="Rrule Toprule">(reference arm for comparison was 25 mg q.d. rilpivirine administered alone)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Rifampin</td>
<td stylecode="Rrule">600 mg q.d.</td>
<td stylecode="Rrule">150 mg q.d.<footnoteref idref="t6fn1"></footnoteref>
</td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">0.31<br/>(0.27–0.36)</td>
<td stylecode="Rrule">0.20<br/>(0.18–0.23)</td>
<td stylecode="Rrule">0.11<br/>(0.10–0.13)</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Sildenafil</td>
<td stylecode="Rrule">50 mg single dose</td>
<td stylecode="Rrule">75 mg q.d.<footnoteref idref="t6fn1"></footnoteref>
</td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">0.92<br/>(0.85–0.99)</td>
<td stylecode="Rrule">0.98<br/>(0.92–1.05)</td>
<td stylecode="Rrule">1.04<br/>(0.98–1.09)</td>
</tr>
</tbody>
</table>